Orthox Closes $12.5M Series A Financing For Clinical Trials Of Knee Cartilage Repair Fibrofix™ Product Platform
Feb 09, 2022•over 3 years ago
Amount Raised
$12.5 Million
Round Type
series a
Description
Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.3m (£3.2m) to close its $12.5m (£9.2m) Series A financing round. The financing will support further clinical trials of its lead product, FibroFixTM, at Southmead Hospital Bristol, UK and in Budapest, Hungary.
FundzWatch™ Score
72
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech